Bid Cap

Company library · Healthcare

Healthcare: the moats, the numbers, the verdicts.

26 companies covered. Every report re-run after the latest earnings.

AbbVie Inc. ABBV

The bet you're really making is that AbbVie's two newer immunology drugs, Skyrizi and Rinvoq, keep growing fast enough to offset the decline of Humira, the former blockbuster that

Company report

Abbott Laboratories ABT

The bet you're really making is that more people keep wearing Abbott's little glucose sensor, the FreeStyle Libre, on their arm, and that its new mail-in colon-cancer test keeps se

Company report

Abivax S.A. ABVX

The bet you're really making is that Abivax's one drug, an oral pill called obefazimod, becomes a standard treatment for ulcerative colitis, a disease where the lining of the large

Company report

Axsome Therapeutics, Inc. AXSM

The bet you're really making is that Auvelity, Axsome's fast-acting depression pill combining dextromethorphan and bupropion, keeps winning patients from older SSRIs, and that a mi

Company report

Bristol-Myers Squibb Company BMY

The bet you're really making is that Bristol-Myers Squibb's newer medicines grow big enough to fill the hole coming when its two largest sellers, the blood thinner Eliquis and the

Company report

Boston Scientific Corporation BSX

The bet you're really making is that Boston Scientific keeps selling more heart devices every year, above all the Farapulse catheter doctors use to fix the irregular heartbeat call

Company report

ClearPoint Neuro, Inc. CLPT

The bet you're really making is that brain surgeons keep choosing ClearPoint's system to steer needles and electrodes into exact spots in the brain while the patient lies inside an

Company report

Halozyme Therapeutics, Inc. HALO

On December 9, 2025 Halozyme granted chief executive Helen Torley a one-time performance share award with a target grant-date fair value of $10,000,012 that pays nothing unless the

Management and incentives · Company report

Hims & Hers Health, Inc. HIMS

The bet you're really making is that Hims & Hers keeps signing up people who want treatment for the things they would rather not raise at a pharmacy counter, hair, sex, skin, and n

Company report · One Pager

IDEXX Laboratories, Inc. IDXX

The bet you're really making is that vets keep installing IDEXX's diagnostic machines, then buying the tests that run on them for years after. Underneath, you're betting American p

Company report

Illumina, Inc. ILMN

The bet you're really making is that the world keeps reading more DNA every year, and that the labs doing it keep buying Illumina's machines and the chemistry kits those machines b

Company report

IQVIA Holdings Inc. IQV

The bet you're really making is that drug companies keep paying IQVIA to run their clinical trials and keep buying its data on what doctors prescribe. Underneath that, you're betti

Company report

Eli Lilly and Company LLY

The bet you're really making is that people keep taking Lilly's weight-loss and diabetes shots, Mounjaro and Zepbound, and that far more people start. You're betting Lilly holds mo

Company report

Mettler-Toledo International Inc. MTD

The bet you're really making is that the world's labs and factories keep needing to measure things precisely, and keep buying Mettler-Toledo's balances, scales and analytical instr

Company report

Nektar Therapeutics NKTR

The bet you're really making is that Nektar's one drug that matters, rezpegaldesleukin (rezpeg), actually clears up moderate-to-severe eczema in two big Phase 3 trials the way it d

Company report

Novo Nordisk A/S NVO

The bet you're really making is that the hundreds of millions of people who could take a weight-loss drug keep choosing Novo's Wegovy and Ozempic, even as Eli Lilly fights for the

Company report

Pfizer Inc. PFE

The bet you're really making is that Pfizer can replace the medicines about to lose their patents fast enough to keep its earnings from shrinking. You're betting the new obesity an

Company report

Rigel Pharmaceuticals, Inc. RIGL

The bet you're really making is that Rigel keeps selling more of its three specialist pills, TAVALISSE, REZLIDHIA and GAVRETO, to the same blood and cancer doctors, and keeps the c

Company report

Royalty Pharma plc RPRX

Royalty Pharma pays Pablo Legorreta a $1,500,000 salary, no bonus, and 20% of the profit on the royalties the company buys, an entitlement its own proxy values at $454.0 million as

Management and incentives · Company report

SELLAS Life Sciences Group, Inc. SLS

The bet you're really making is that one of SELLAS's two cancer drugs actually works in a blood cancer called AML, and that a trial reads out well enough to win FDA approval. You'r

Company report

Tarsus Pharmaceuticals, Inc. TARS

The bet you're really making is that Tarsus keeps selling more Xdemvy, the eye drops that kill the mites living at the base of people's eyelashes, and that most of the roughly 25 m

Company report

Universal Health Services, Inc. UHS

The bet you're really making is that Universal Health keeps its beds full, the acute-care hospitals and the psychiatric and addiction-treatment centers, and keeps getting paid for

Company report

UnitedHealth Group Incorporated UNH

The bet you're really making is that UnitedHealth stops paying out more in medical bills than it planned, so its profit climbs back toward where it stood two years ago. You're bett

Company report

Viking Therapeutics, Inc. VKTX

The bet you're really making is that Viking's obesity drug VK2735, delivered as both a weekly injection and a daily pill, works roughly as well as the blockbuster drugs from Eli Li

Company report

West Pharmaceutical Services, Inc. WST

The bet you're really making is that the rubber stoppers and seals West puts on injectable-drug vials and syringes stay locked in, because once a drug is approved with West's exact

Company report

Zoetis Inc. ZTS

The bet you're really making is that people keep spending on their dogs and cats no matter what the economy does, and keep buying Zoetis's medicines to stop the itching, kill the f

Company report